Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501YMA30 Strain of SARS-CoV-2Karen V. Kibler, Bertram L. Jacobs, Masmudur M. Rahman et al.|Vaccines|2022Cited by 14
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y <sub>MA30</sub> strain of SARS-CoV-2Karen V. Kibler, Bertram L. Jacobs, Mateusz Szczerba et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 8